Basel Medical Group Ltd Ordinary Shares
BMGL | NASDAQ
$5.06
+$0.02 (+0.40%)
Nov 2, 2026, 2:28 PM ET · Market open
Fiscal Year Period Ending | FY 2024 Jun 30, 2025 | FY 2023 Jun 30, 2024 | FY 2022 Jun 30, 2023 | FY 2021 Jun 30, 2022 |
|---|---|---|---|---|
PE Ratio | -5.26 | 63.61 | 74.68 | 68.92 |
PEG Ratio | 0.01 | 3.60 | -7.34 | n/a |
PS Ratio | 3.76 | 9.73 | 10.06 | 9.40 |
PB Ratio | 8.75 | 12.93 | 17.77 | 27.05 |
P/FCF Ratio | -9.66 | 39.09 | 37.61 | 37.07 |
P/OCF Ratio | -9.79 | 38.97 | 37.52 | 35.90 |
OCF/S Ratio | -38.38 | 24.97 | 26.80 | 26.20 |
Debt / Equity Ratio | 0.70 | 0.57 | 1.31 | 2.74 |
Quick Ratio | 1.19 | 2.25 | 2.27 | 2.17 |
Current Ratio | 1.23 | 2.26 | 2.28 | 2.18 |
Asset Turnover | 0.67 | 0.62 | 0.63 | 0.63 |
Interest Coverage | -10.70 | 12.46 | 8.39 | 7.71 |
Return on Equity | -248.66% | 27.41% | 32.49% | 53.38% |
Return on Assets | -71.72% | 12.71% | 11.59% | 11.74% |
Return on Invested Capital | -25.47% | 15.97% | 13.19% | 14.80% |
Dividend Yield | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a |
FCF Payout Ratio | n/a | n/a | n/a | n/a |
Gross Profit Margin | 77.68% | 77.63% | 75.91% | 79.56% |
Net Profit Margin | -106.78% | 20.62% | 18.38% | 18.56% |
Pretax Profit Margin | -110.47% | 23.92% | 21.97% | 22.39% |
Operating Profit Margin | -19.28% | 21.84% | 20.64% | 23.21% |
FCF Margin | -38.86% | 24.89% | 26.74% | 25.37% |
EBITDA Margin | -98.24% | 30.94% | 30.17% | 30.80% |
Add to Watchlist
Select watchlists to add or remove BMGL